BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.
The UK’s premier immunology event, taking place on 5-8 December, welcomes over 1500 attendees – including scientists, researchers and clinical specialists – to witness a fascinating fusion of innovative research from around the world.
The BSI Congress is an in-person and virtually accessible event with an exciting and comprehensive programme, including an insightful presentation from Graham Johnson, Managing Director of BIOHIT HealthCare, about GastroPanel. This simple and non-invasive blood test assesses the structure and function of the stomach to accurately detect atrophic gastritis, a pre-neoplastic condition of the gastric mucosa associated with several autoimmune disorders, including autoimmune thyroiditis, pernicious and iron-deficiency anaemia. Visitors can also expect a wide range of other exciting seminars, covering topics such as neuroimmunology, tropical diseases, immunodeficiency, tissue immunology, immunotherapy and systems immunology.
The BIOHIT team will be showcasing its comprehensive range of therapeutic drug monitoring (TDM) assays at the conference too. These tests can determine a patient’s response to various treatments, providing critical information to guide clinicians’ decision-making in the development of individualised care plans for chronic inflammatory disease. And GastroPanel will also be on show, so visitors can learn about its potential to speed up investigative pathways for patients with digestive complaints. Representatives from BIOHIT will be at stand 31, and will be on hand to meet as many guests as possible to demonstrate what the company can offer.
Click here to request a personal meeting with BIOHIT at the event.
